4.0 Article

Continuous Glucose Monitoring Profiles in Healthy, Nondiabetic Young Children

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study

Andrea K. Steck et al.

Summary: Continuous glucose monitoring (CGM) metrics can be used to predict the risk of children with persistently positive islet autoantibodies progressing to clinical diabetes. Higher average sensor glucose levels and increased glycemic variability are predictive factors. Children with more than 10% of time spent with glucose levels above 140 mg/dL have a high risk of developing clinical diabetes within one year. CGM should be included in the monitoring of high-risk children and could be used as an entry criterion for prevention trials.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Emily K. Sims et al.

Summary: Most screening programs for type 1 diabetes identify individuals at risk through relatives, but many patients don't have a family history. Recent advancements in disease-modifying therapies have sparked interest in population screening. Existing programs rely on genetic or autoantibody screening, which have provided valuable insights into disease progression and screening timing.

DIABETES (2022)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring Profiles in Healthy, Nondiabetic Young Children

Stephanie N. DuBose et al.

Summary: This study aimed to establish reference glucose ranges in healthy young children without diabetes and found that these children had an average glucose level of 103 mg/dL (5.7 mmol/L), spent most of their time within the range of 70-140 mg/dL (3.9-7.8 mmol/L), and had minimal time below 70 mg/dL (3.9 mmol/L).

JOURNAL OF THE ENDOCRINE SOCIETY (2022)

Article Endocrinology & Metabolism

CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study

Andrea K. Steck et al.

Summary: This study indicates that continuous glucose monitoring data above specific glucose levels are closely associated with the risk of antibody-positive children progressing to clinical diabetes. CGM may be an important tool for monitoring and prevention trials for high-risk children.

DIABETES CARE (2022)

Article Medicine, General & Internal

Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany

Anette-Gabriele Ziegler et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Endocrinology & Metabolism

Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado

R. Brett McQueen et al.

DIABETES CARE (2020)

Editorial Material Endocrinology & Metabolism

Continuous Glucose Monitoring-Derived Data Report-Simply a Better Management Tool

Tadej Battelino et al.

DIABETES CARE (2020)

Article Endocrinology & Metabolism

One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes

Kimber M. Simmons et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study

Viral N. Shah et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Medicine, General & Internal

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Endocrinology & Metabolism

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018

Nicole C. Foster et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

Brandon M. Nathan et al.

DIABETES CARE (2017)

Article Endocrinology & Metabolism

Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth

Kendra Vehik et al.

DIABETES CARE (2012)